CNS & Neurological Disorders-Drug Targets

Papers
(The TQCC of CNS & Neurological Disorders-Drug Targets is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Meet the Editorial Board Member89
Meet the Regional Editor78
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation55
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus55
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 51
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment48
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives46
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis42
Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation35
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis33
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation33
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease29
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a 28
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders26
Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer's Disease26
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound25
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson’s Disease: Exploring Nanoparticle-based Gene Therapies25
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease24
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia23
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review23
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature22
Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches21
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis21
Insights into the Diagnosis, Treatment, and Management of Prion Diseases21
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota21
Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments20
Clozapine in a Young Female with Drug-Resistant Schizophrenia: A Case Report of Development of Serositis20
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health20
Are Lysosomes Potential Therapeutic Targets for Parkinson’s Disease?20
Neuropharmacological Activity of the New Piperazine Derivative 2-(4-((1- Phenyl-1H-Pyrazol-4-yl)Methyl)Piperazin-1-yl)Ethyl Acetate is Modulated by Serotonergic and GABAergic Pathways20
A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease19
Vasospasm in Pediatric Subarachnoid Hemorrhage19
A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease19
WITHDRAWN: Nigella Fixed Oil Mitigates Memory Impairment in a Rat-Aged Model of Cognitive Decline; A Pivotal Role of BDNF and CREB Signaling Pathways in the Hippocampus18
High-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Accelerates onset Time of Beneficial Treating Effects and Improves Clinical Symptoms of Depression18
An Overview of the Natural Neuroprotective Agents for the Management of Cognitive Impairment Induced by Scopolamine in Zebrafish (Danio rerio)18
Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761®) in Patients with Amnestic Mild Cognitive Impairment18
Analysis of Concentrations of Monomethyl Fumarate in Patients with Multiple Sclerosis: Result from Routine Health Care18
Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol17
The Landscape of Randomized Clinical Trial Meta-analyses on Statins for Aneurysmal Subarachnoid Hemorrhage: A Scoping Review16
Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine16
Hematological Consequences of Valproic Acid in Pediatric Patients: A Systematic Review with a Mechanistic Approach16
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings15
Evolutionary Unmasking Resuscitative Therapeutics Potential of Centhaquin Citrate in Hypovolemic Shock15
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models15
Navigated Transcranial Magnetic Stimulation (nTMS) based Preoperative Planning for Brain Tumor Treatment14
Decoding the Gut-Brain Axis in Alzheimer's Disease: Emerging Perspectives14
Comparison of the Sedative Effect of Ketamine, Magnesium Sulfate, and Propofol in Patients Undergoing Upper Gastrointestinal Endoscopy: Double-Blinded Randomized Clinical Trial14
Genetic Predisposition and Severity of Eating Disorders- A Review14
An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease14
Natural Products as Bioactive Agents in the Prevention of Dementia14
Exploring the Potential of Herbal Compounds as Autophagy Modulators in Alzheimer's Disease: A Comprehensive Review14
Obesity and Depression: Common Link and Possible Targets14
Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article13
The Effects and Regulatory Mechanism of Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi in Promoting Neurogenesis and Improving Memory Impairment Mediated by the BDNF-ERK-CREB Signa13
Bis-iodine-labeled Curcumin as a Potential CT Imaging Agent for β-amyloid Plaques in the Brain13
Emerging Treatments for Subarachnoid Hemorrhage13
Dietary Nutrients and Prevention of Alzheimer’s Disease13
Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology13
Acknowledgements to Reviewers13
COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?13
Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review13
Phosphodiesterase 2 and Its Isoform A as Therapeutic Targets in the Central Nervous System Disorders13
Approaches for Ear-targeted Delivery Systems in Neurosensory Disorders to avoid Chronic Hearing Loss Mediated Neurological Diseases13
Acknowledgements to Reviewers12
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series12
Meet the Editorial Board Member12
Neuroprotection or Sex Bias: A Protective Response to Traumatic Brain Injury in the Females12
Lithium Chloride Rescues Dopaminergic Neurons in a Parkinson’s Disease Rat Model Challenged with Rotenone12
The Potential Role of Dopamine Pathways in the Pathophysiology of Depression: Current Advances and Future Aspects12
Arachidonic Acid Derivatives and Neuroinflammation12
Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders12
One-Trial Appetitive Learning Tasks for Drug Targeting11
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO11
WITHDRAWN: Neurological Studies Of Herbal Medicinal Plants For The Treatment Of Memory Impairment: A Review11
Pharmacotherapy in SAH: Clinical Trial Lessons11
Lorcaserin: Worthy of Further Insights? Results from Recent Research11
Valproate Exposure as an In vitro Model for Studying Morpho-Molecular Features of ASD: A Systematic Review11
Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors11
Nanoparticle-Based Approaches for Glioblastoma Treatment: Advances and Future Prospects11
The Peripheral Profile of the Chitinase 3-like-1 in Benign Multiple Sclerosis – A Single Centre’s Experience10
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease10
Arachidonic Acid Metabolites in Neurologic Disorders10
Rationalizing the Use of Polyphenol Nano-formulations in the Therapy of Neurodegenerative Diseases10
Modulation of Huntington’s Disease in Drosophila10
Benzodiazepines and Sleep Architecture: A Systematic Review10
Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders10
Endophenotypes and Pathway Phenotypes in Neuro-psychiatry: Crossdisciplinary Implications for Diagnosis10
Neurological Manifestations Following Traumatic Brain Injury: Role of Behavioral, Neuroinflammation, Excitotoxicity, Nrf-2 and Nitric Oxide10
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities10
Nanotechnological Advances in the Treatment of Epilepsy10
Rethinking Catatonia: New Insights from the Autism Spectrum10
Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm10
Meet the Editorial Board Member9
Nicotine Abuse and Neurodegeneration: Novel Pharmacogenetic Targets to Aid Quitting and Reduce the Risk of Dementia9
Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights9
Design and Molecular Docking Studies of N-Mannich Base Derivatives of Primaquine Bearing Isatin on the Targets involved in the Pathophysiology of Cerebral Malaria9
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets9
In Vivo Antidepressant Efficacy of 3-Substituted Thietane-1,1-dioxide Derivative - A Preliminary Study for Novel Anti-Depression Therapy in Neurological Disorders9
The Protective Role of L-carnitine on Psychosocial Stress-induced Changes in Gene Expression and Protein Levels of Matrix Metalloproteinases, Serum Corticosterone in a Rat Model9
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease9
Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment9
Peripheral Vascular Disease is Associated with Impaired Activities of Daily Living in the Elderly with Dementia: A Prospective Study8
Acute Peripheral Facial Nerve Palsy in Children and Adolescents: Clinical Aspects and Treatment Modalities8
Neurodegenerative Disorders and the Current State, Pathophysiology, and Management of Parkinson’s Disease8
Preface8
Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer’s Disease8
Ameliorating Effects of Virgin Coconut Oil (VCO) on Nicotine Dependence and Quality of Life in Smokers8
Anaesthesia-induced Changes in Genomic Expression Leading to Neurodegeneration8
Neurotoxicity of Endogenous Neurotoxin Salsolinol in Parkinson's Disease8
Parkinson’s Disease: A Progressive Neurodegenerative Disorder and Structure-Activity Relationship of MAO Inhibitor Scaffolds as an Important Therapeutic Regimen8
Zederone Improves the Fecal Microbial Profile in Dementia Induced Rat Model: A First Report8
Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorder in Children: A Randomized Controlled Trial8
Valproic Acid and Celecoxib Enhance the Effect of Temozolomide on Glioblastoma Cells8
Role of Unani Polyherbal Formulations in the Treatment of Diseases with Special Reference to Neurodegenerative Disorders8
The Role of Ca2+ Permeable AMPA Receptors in Neurodegeneration, Neurotoxicity, and Neuroinflammation8
Imbalance of Th1 and Th2 Cytokines and Stem Cell Therapy in Pathological Pain8
The Possible Protective Effect of Taurine on Bisphenol Induced Structural Changes on the Cerebral Cortex of Rats: Histological and Immunohistochemical Study7
Meet the Editorial Board Member7
Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis7
An Overview of Acute Flaccid Myelitis7
Role of Lipocalin-2 in N1/N2 Neutrophil Polarization After Stroke7
Brain-Derived Neurotrophic Factor – The Protective Agent Against Neurological Disorders7
Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects7
The Protective Effects of Pioglitazone Against Cognitive Impairment Caused by L-methionine Administration in a Rat Model7
A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease7
Pre-clinical Aspects and Contemporary Treatments of Parkinson’s Disease7
Foresee Novel Targets for Alzheimer’s Disease by Investigating Repurposed Drugs7
In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity7
Flow Diversion for the Management of Posterior Circulation’s Intracranial Aneurysms7
Association between Frequency of Seizures and Number of Antiseizure Medications (ASM) in Patients with Epilepsy7
Structural Activity Relationship based Medicinal Perspectives of Pyrimidine Derivatives as Anti-Alzheimer’s Agents: A Comprehensive Review7
Preface7
Metabolic Disorder Therapeutics and their Effects on Memory7
Role of Imaging Genetics in Alzheimer’s Disease: A Systematic Review and Current Update7
How Do Abnormalities in the Cerebrospinal Fluid Impact Neuropsychology with Progressing Age?7
An Insight into Medicinal Chemistry and SAR Studies of Cholinesterase and BACE-1 Inhibitors for Alzheimer's Disease7
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety7
Early Detection of Glioma: Investigating Inflammatory Markers (CRP), Kidney, and Liver Function7
Abnormality of Voltage-Gated Sodium Channels in Disease Development of the Nervous System. A Review Article7
WITHDRAWN: Neuroprotective Effect of 3,3′-Diindolylmethane and ɑ-Naphthoflavone, Aryl Hydrocarbon Receptor Modulators, in an Experimental Model of Ischemic Stroke7
Meet the Editorial Board Member7
Neural Basis of Dental Pulp Stem Cells and its Potential Application in Parkinson’s Disease7
0.19273900985718